(Q44242400)

1 December 2017

Prevalence of PALB2 mutation c.509_510delGA in unselected breast cancer patients from Central and Eastern Europe (English)

1 reference

1 December 2017

1 reference

6

1 reference

1 December 2017

Thilo Dörk

11

0 references

Tjoung-Won Park-Simon

series ordinal

9

object named as

Tjoung-Won Park-Simon

1 reference

1 December 2017

3

Marina Bermisheva

1 reference

1 December 2017

2

Natalia Bogdanova

1 reference

1 December 2017

10

Peter Hillemanns

1 reference

1 December 2017

5

Natalia Antonenkova

1 reference

1 December 2017

7

Michael Bremer

1 reference

1 December 2017

Monika Noskowicz

1

1 reference

1 December 2017

Zalina Takhirova

series ordinal

4

1 reference

1 December 2017

Hans Christiansen

series ordinal

8

1 reference

1 December 2017

language of work or name

1 reference

1 June 2014

1 reference

1 December 2017

1 reference

1 December 2017

13

1 reference

1 December 2017

2

1 reference

1 December 2017

137-142

1 reference

https://scigraph.springernature.com/pub.10.1007/s10689-013-9684-1

1 December 2017

0 references

cites work

Genetic predisposition to breast cancer: past, present, and future

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

Hereditary breast cancer: new genetic developments, new therapeutic avenues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

Susceptibility pathways in Fanconi's anemia and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

PALB2 is an integral component of the BRCA complex required for homologous recombination repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

PALB2/FANCN: recombining cancer and Fanconi anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

A recurrent mutation in PALB2 in Finnish cancer families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

Penetrance analysis of the PALB2 c.1592delT founder mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

Contribution of the PALB2 c.2323C>T [p.Q775X] founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

A novel germline PALB2 deletion in Polish breast and ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

PALB2 mutations in German and Russian patients with bilateral breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

Genome-wide association study identifies novel breast cancer susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

Nijmegen Breakage Syndrome mutations and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom's syndrome, is associated with breast cancer in Slavic populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

Large-scale genotyping identifies 41 new loci associated with breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

Analysis of PALB2/FANCN-associated breast cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

PALB2: a novel inactivating mutation in a Italian breast cancer family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

Rare germline mutations in PALB2 and breast cancer risk: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-013-9684-1

High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus

21 January 2018

1 reference

12 December 2020

CHEK2 Mutation and Hereditary Breast Cancer

1 reference

12 December 2020

Association of two mutations in theCHEK2 gene with breast cancer

1 reference

12 December 2020

The incidence of PALB2 c.3113G>A in women with a strong family history of breast and ovarian cancer attending familial cancer centres in Australia.

1 reference

12 December 2020

10.1007/S10689-013-9684-1

Identifiers

DOI

1 reference

1 December 2017

1 reference